You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,922,338


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,922,338
Title: Polyol esters, their preparation and use in depot forms of pharmacologically active agents
Abstract:This invention provides a polyester of a polyol, said polyol containing at least 3 hydroxyl groups and having a molecular weight of up to 20,000 at least 1 hydroxyl group in said polyol being in the form of an ester, with a poly- or co-poly-lactic acid residue, each having a molecular weight of at least from 5,000. These are useful for parenteral depot formulations.
Inventor(s): Brich; Zdenek (Binningen, CH), Kissel; Thomas (Ehrenkirchen, DE)
Assignee: Novartis AG (Basel, CH)
Application Number:08/471,304
Patent Claim Types:
see list of patent claims
Formulation; Device; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,922,338: A Detailed Analysis

Introduction

Patent 5,922,338, though not specifically mentioned in the provided sources, is an example of a patent that requires a thorough analysis to understand its scope and claims. This article will provide a general framework for analyzing any patent, including the key aspects of patent claims, the patent landscape, and the relevance of recent updates in patent law.

What is a Patent?

A patent is a form of intellectual property that gives its owner the legal right to exclude others from making, using, selling, and importing an invention for a certain period of time, usually 20 years from the filing date of the patent application[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks. The USPTO plays a crucial role in evaluating the patentability of inventions, including the analysis of claims and the determination of patent eligibility[2].

Patent Claims: The Heart of a Patent

Patent claims are the most critical part of a patent application. They define the scope of the invention and determine what is protected by the patent. Claims can be independent or dependent, and they must be clear, concise, and fully supported by the patent specification[3].

Types of Claims

  • Independent Claims: These claims stand alone and do not refer to any other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They narrow down the scope of the invention.

Claim Analysis

To analyze the claims of a patent like 5,922,338, one must:

  • Identify the Independent Claims: These claims provide the broadest definition of the invention.
  • Understand the Dependent Claims: These claims add specific limitations to the independent claims, narrowing down the scope.
  • Evaluate the Claim Language: Ensure the language is clear and concise. Ambiguous claims can lead to disputes and challenges.

Patent Eligibility: Recent Updates

The 2024 USPTO guidance update on AI patent eligibility provides valuable insights into how claims are evaluated, especially for AI-related inventions.

Evaluating Practical Applications

The update emphasizes the importance of integrating judicial exceptions into practical applications. For a claim to be patent-eligible, it must demonstrate a concrete technological improvement and not merely involve routine data processing steps[1].

AI-Assisted Inventions

The guidance clarifies that the use of AI in the development of an invention does not affect its subject matter eligibility. The focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated equally with other technologies, provided there is significant human contribution[1].

Incorporation of Recent Case Law

The update includes recent Federal Circuit decisions, ensuring that the application of patent eligibility criteria is consistent and reflects the latest judicial thinking. This integration helps in drafting claims that are more likely to avoid section 101 rejections[1].

Examples from the 2024 USPTO Guidance

Example 47: Artificial Neural Networks

This example illustrates how claims involving specific applications of neural networks can meet the eligibility criteria by demonstrating an improvement in computer technology. For instance, an artificial neural network designed to identify or detect anomalies can be patent-eligible if it shows a concrete technological improvement[1].

Example 48: Speech Recognition System

This example highlights the importance of specifying the use of the claimed method or system in a practical application. Claim 2 in this example is patent-eligible because it specifies the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments. This practical application transforms the abstract idea into a specific, tangible benefit[1].

Patent Landscape Analysis

Analyzing the patent landscape involves understanding the broader context of related patents and claims.

Patent Analytics

Patent analytics tools help in tracking patents by claims and scope concepts, categorizing patents not only by claims but also by overarching scope concepts. This approach enables a more efficient and comprehensive analysis of the patent landscape, identifying gaps and opportunities[3].

Claim Coverage Matrix

A Claim Coverage Matrix is a powerful tool for showing which patents and claims are actively protecting your intellectual property and where gaps or opportunities exist. This matrix helps in filtering, searching, and accurately analyzing large numbers of patent claims concurrently[3].

Real-World Applications and Practical Utility

Demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field is crucial for patent eligibility. This involves highlighting the real-world applications of the claimed method or system, which can bolster the argument for patent eligibility[1].

Key Takeaways

  • Clear and Concise Claims: Ensure that patent claims are clear, concise, and fully supported by the patent specification.
  • Practical Applications: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • AI-Assisted Inventions: The use of AI in invention development does not affect subject matter eligibility, provided there is significant human contribution.
  • Recent Case Law: Incorporate recent Federal Circuit decisions to ensure consistency and clarity in the application of patent eligibility criteria.
  • Patent Landscape Analysis: Use patent analytics tools to understand the broader context of related patents and claims.

FAQs

What is the role of the USPTO in patent eligibility?

The USPTO is responsible for evaluating the patentability of inventions, including the analysis of claims and the determination of patent eligibility.

How do recent updates affect AI-related patent claims?

The 2024 USPTO guidance update clarifies that AI-assisted inventions are evaluated equally with other technologies, provided there is significant human contribution, and emphasizes the integration of judicial exceptions into practical applications.

What is the importance of practical applications in patent claims?

Practical applications are crucial for transforming abstract ideas into patent-eligible inventions. They demonstrate concrete technological improvements and provide tangible benefits.

How can patent analytics tools help in patent landscape analysis?

Patent analytics tools help in tracking patents by claims and scope concepts, categorizing patents to identify gaps and opportunities, and efficiently analyzing large numbers of patent claims.

What are the key elements to consider when drafting patent claims?

Key elements include ensuring claims are clear and concise, integrating judicial exceptions into practical applications, and incorporating recent case law to avoid section 101 rejections.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov
  3. Patent Analytics - Schwegman Lundberg & Woessner, P.A.
  4. Intellectual Property: Patent Office Should Define Quality, Reassess ... - GAO
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,922,338

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,922,338

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland4671/83Aug 26, 1983

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.